Evidence map›Paper›PMID 35666870›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Alternative splicing encodes functional intracellular CD59 isoforms that mediate insulin secretion and are down-regulated in diabetic islets.

Ewelina Golec, Alexander Ekström, Maciej Noga, Muhmmad Omar-Hmeadi, Per-Eric Lund, Bruno O Villoutreix, Ulrika Krus, Katarzyna Wozniak, Olle Korsgren, Erik Renström and 3 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological Niche.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. The multiverse of CD46 and oncologic interactions.The Journal of clinical investigation · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Complement, complosome, and complotype: A perspective.European journal of immunology · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Complosome - the intracellular complement system.Nature reviews. Nephrology · 2023
    Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Ewelina GolecSection of Medical Protein Chemistry, Department of Translational Medicine, Lund University, 214-28 Malmö, Sweden.
Alexander EkströmSection of Medical Protein Chemistry, Department of Translational Medicine, Lund University, 214-28 Malmö, Sweden.ORCID 0000-0003-2310-2643
Maciej NogaSection of Medical Protein Chemistry, Department of Translational Medicine, Lund University, 214-28 Malmö, Sweden.
Muhmmad Omar-HmeadiDepartment of Medical Cell Biology, Uppsala University, BMC 571, 75123 Uppsala, Sweden.
Per-Eric LundDepartment of Medical Cell Biology, Uppsala University, BMC 571, 75123 Uppsala, Sweden.
Bruno O VilloutreixUniversité Paris Cité, Department of Neuroscience, NeuroDiderot, Inserm U1141, Paris, F-75019 France.
Ulrika KrusLund University Diabetes Centre, Department of Clinical Sciences Malmö, Lund University, 214-28 Malmö, Sweden.
Katarzyna WozniakSection of Medical Protein Chemistry, Department of Translational Medicine, Lund University, 214-28 Malmö, Sweden.
Olle KorsgrenDepartment of Immunology, Genetics, and Pathology, Uppsala University, 751 85 Uppsala, Sweden.ORCID 0000-0002-8524-9547
Erik RenströmLund University Diabetes Centre, Department of Clinical Sciences Malmö, Lund University, 214-28 Malmö, Sweden.
Sebastian BargDepartment of Medical Cell Biology, Uppsala University, BMC 571, 75123 Uppsala, Sweden.ORCID 0000-0003-4661-5724
Ben C KingSection of Medical Protein Chemistry, Department of Translational Medicine, Lund University, 214-28 Malmö, Sweden.ORCID 0000-0001-6776-8741
Anna M BlomSection of Medical Protein Chemistry, Department of Translational Medicine, Lund University, 214-28 Malmö, Sweden.ORCID 0000-0002-1348-1734
Joslin Diabetes Center · USUppsala University · SELund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human pancreatic islets highly express CD59, which is a glycosylphosphatidylinositol (GPI)-anchored cell-surface protein and is required for insulin secretion. How cell-surface CD59 could interact with intracellular exocytotic machinery has so far not been described. We now demonstrate the existence of CD59 splice variants in human pancreatic islets, which have unique C-terminal domains replacing the GPI-anchoring signal sequence. These isoforms are found in the cytosol of β-cells, interact with SNARE proteins VAMP2 and SNAP25, colocalize with insulin granules, and rescue insulin secretion in CD59-knockout (KO) cells. We therefore named these isoforms IRIS-1 and IRIS-2 (Isoforms Rescuing Insulin Secretion 1 and 2). Antibodies raised against each isoform revealed that expression of both IRIS-1 and IRIS-2 is significantly lower in islets isolated from human type 2 diabetes (T2D) patients, as compared to healthy controls. Further, glucotoxicity induced in primary, healthy human islets led to a significant decrease of IRIS-1 expression, suggesting that hyperglycemia (raised glucose levels) and subsequent decreased IRIS-1 expression may contribute to relative insulin deficiency in T2D patients. Similar isoforms were also identified in the mouse CD59B gene, and targeted CRISPR/Cas9-mediated knockout showed that these intracellular isoforms, but not canonical CD59B, are involved in insulin secretion from mouse β-cells. Mouse IRIS-2 is also down-regulated in diabetic db/db mouse islets. These findings establish the endogenous existence of previously undescribed non–GPI-anchored intracellular isoforms of human CD59 and mouse CD59B, which are required for normal insulin secretion.

Indexed as

Alternative SplicingDiabetes MellitusCD59 AntigensHumansInsulin SecretionProtein IsoformsCD59 AntigensCD59 protein, humanProtein IsoformsCD59insulin secretionintracellular complementSNAREstype 2 diabetes

Identifiers

PMID35666870
PMCPMC9214515
OpenAlexW4282936951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.